Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Music
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/92/64/ae/9264aec2-1bdc-aea3-4b83-3226c5aaadb5/mza_14365421335624065445.jpg/600x600bb.jpg
New Retina Radio by Eyetube
Retina Today
217 episodes
2 days ago
New Retina Radio is a place to hear stories about retina that are told nowhere else.
Show more...
Science
Technology
RSS
All content for New Retina Radio by Eyetube is the property of Retina Today and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
New Retina Radio is a place to hear stories about retina that are told nowhere else.
Show more...
Science
Technology
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/92/64/ae/9264aec2-1bdc-aea3-4b83-3226c5aaadb5/mza_14365421335624065445.jpg/600x600bb.jpg
Late-Breaking Talks at AAO '25: Gene Therapy for RP and NPDR
New Retina Radio by Eyetube
25 minutes
1 week ago
Late-Breaking Talks at AAO '25: Gene Therapy for RP and NPDR
Could optogenetics represent the innovative thinking needed to restore some function in retinitis pigmentosa (RP) patients? Allen Ho, MD, joins us to discuss the state of play in optogenetics, specifically regarding MCO-010 (Nanoscope Therapeutics). What have we seen in the several years since the first patients with RP were dosed with MCO-010 in the RESTORE study? And Charles Wykoff, MD, PhD, joins us to review data assessing the safety and efficacy of sura-vec (Regenxbio/AbbVie) for the treatment of non-proliferative diabetic retinopathy. What do patients look like at 2 years after a single suprachoroidal injection? Listen in to find out.  
New Retina Radio by Eyetube
New Retina Radio is a place to hear stories about retina that are told nowhere else.